|
Return to This web site was created by Division M, which is responsible for its
contents.
Created 1.25.98, revised 9.10.05. Please send corrections to Eric Miller eric_miller@ncsu.edu Thanks to: Susan Godfrey ssg1@pitt.edu andRoger Hendrix rhx@pitt.edu for the original design of these pages Copyright © 1998- 2005 American Society for Microbiology, all rights reserved. |
Division M is composed of researchers and teachers dedicated to the study of
bacterial viruses. Current topics of interest are: assembly and structure, genome
structure, initiation of infection, regulation of transcription and
translation, replication, recombination, repair, virus-host interactions,
new phage systems, molecular cloning technology, applications of phage & phage products, and bacteriophage evolution.
What is a bacteriophage, anyway?
A brief introduction to the beast, complete with pronunciation
guide.
Members of Division M certainly know what bacteriophages are, but other readers
of this page may wonder what it is about these tiny microorganisms that would make so
many scientists devote their professional lives to understanding
how they work. This part of the site provides a brief primer for the
uninitiated about what bacteriophages are, what they do, and what they do for us; and
gives a quick refresher for those who once knew something about bacteriophages.
Teachers who wish to include bacteriophages in their
curricula will find some useful links in our "Resources for teachers", "Books", and "Links" pages.
Bacteriophages (phages for short) are viruses whose hosts are bacterial
cells. Like all viruses, phages are metabolically inert in their
extracellular form (the
virion), and they reproduce by insinuating themselves into the
metabolism of the host. The mechanisms by which phage virions infect their host
cellsdescribed in more detail belowvary among the different
types of phages, but they all result in delivery of the phage genome into the
cytoplasm of the bacterial host, where it interacts with the cellular machinery to carry the
phage life cycle forward. The result of infection can be, and often is, total devastation
for the cell. A good example of this is infection by the E. coli phage T4, the
Tyrannosaurus rex of phages, which commandeers the material and energetic resources
of the cell and turns them toward making more virions, after which it causes violent
lysis of the cell and release of the progeny virions. At another extreme, the large group of
phages known as
Follow this link for guidance on pronouncing
the words bacteriophage and phage.
There are probably more individual bacteriophages in the biosphere than
there are of any other group of organisms, including all the
The tailed phages are also known as the dsDNA tailed phages because their genomes
are molecules of linear double-stranded DNA. Their genomes are relatively large
for viruses, with most of them in the vicinity of 50 kbp (50,000 base pairs). However,
some are less than 20 kbp, the common and well studied T4-like group is more
like 160 kbp, and bacteriophage G is the largest virus on record, with a genome of nearly
500 kbpbigger than the smallest bacterial genomes.
Although the dsDNA tailed phages account for about 95% of all phages reported in the
scientific literature, and may in fact make up the majority of phages on the planet,
there are other phages that occur abundantly in the Biosphere sporting very different virions,
genomes, and lifestyles. These are listed in more detail in the "Phage Facts & Portraits" pages on this site, but they include phages with ssDNA, ssRNA, or segmented dsRNA genomes,
virions with and those without membrane components, and many other differences.
In fact, the diversity of phages is at least as great as the diversity of plant and animal viruses, in keeping with the probability that phages and viruses of
Bacteriophages were discovered a little over 80 years agoin 1915 by the
Englishman Frederick Twort and independently in 1917 by the French Canadian
Félix
DHerelle. Initial research on phage was concerned with defining the
nature of the bacteriophagethe two leading theories being that it was a
filterable virus, like the Tobacco Mosaic Virus that had been discovered some 20 years
earlier, or a self-perpetuating enzyme whose expression caused destruction of
the bacterial cell.
Regardless of the exact nature of the bacteriophage, it was quickly
realized that bacteriophages had the potential to kill the bacteria that cause many
infectious diseases in humans, as well as in agriculturally important plants and animals. This
idea formed the basis for much research as well as for the Pulitzer Prize-winning 1924
novel Arrowsmith by Sinclair Lewis (still a good read).
Félix
DHerelle in particular was a champion of the potential for
therapeutic uses of phage, which he promoted vigorously. In 1933, DHerelle
co-founded an institute for phage research in the Soviet Republic of Georgia, together with
Georgian microbiologist George Eliava. Although Eliava was killed in one of
Stalins purges in 1937, and DHerelle never returned, the G. Eliava Institute of Bacteriophage survived and continued to supply phage for therapeutic uses to
the entire Soviet Union until the recent breakup of the Soviet Union. In the
West, research on such phage therapy was dropped when penicillin and
other chemical antibiotics were discovered starting in the 1940s, though there
has been some renewed interest in
phage therapy
in recent years as antibiotic
resistance of pathogenic bacteria has become a more prominent threat to public health.
Meanwhile, bacteriophage research continued. The viral nature of the bacteriophage
was clearly established, the chemical composition of the virions (the extracellular virus
particles) was measured and shown to be protein and DNA, new phages infecting a
variety of bacterial hosts were isolated, and some rudimentary progress was
made in understanding the virus life cycle. The first electron micrographs of phages,
showing a tadpole-like shape, were obtained in 1942 by Tom Anderson.
The modern era of bacteriophage research is usually dated
from 1938 when the expatriate German physicist, Max Delbrück, began his work on phages
at the California Institute of Technology. Salvadore Luria, an Italian expatriate at
Indiana University (later at MIT) and Al Hershey, an American at Vanderbilt University
(later at Cold Spring Harbor) soon joined Delbrück in pursuing bacteriophage research
as a route to understanding the most fundamental features of biological life.
Phages soon became central players in the foundation
of the discipline that later came to be known as molecular biology (the Journal of Molecular
Biology started publication in 1959). Through the 1950s and 1960s, phage
research had a dominant role in elucidating the most
fundamental facts about what genes
are and how the information in genes is read out to determine the properties of an organism.
An underlying assumption (and justification) of the early phage molecular biologists was that
the principles of life that could be learned from phages would also apply to other forms of life.
As it has become clear in subsequent decades just how remarkably correct that assumption was,
it has become similarly clear that the history of phage biology is a major and essential part
of the modern history of biology as a whole.
The astonishing success of bacteriophage research over the 25-30 years prior
to about 1970 in revealing the fundamental secrets
of life can be attributed largely to the fact that phages are so
tractable as experimental systems. That is, they are genetically and structurally simple,
they have a short
Around 1970 the world of biological research began to be transformed by the
Because phages attack bacteria, and bacteria are sometimes harmful to people, many phage biologists believe it is possible to use phage or phage products (such as phage-encoded enzymes) as disease therapy or in other ways to solve our bacterial problems. At this writing, with a few exceptions, these techniques are in research stages rather than in actual use.
Examples include treatment of particular bacterial infections or infestations with specific phage, treatment of bacterial infections with phage products, and use of phage-encoded toxins to combat cancer.
Among the issues that need resolution before application of these methods becomes practical are how the phage-based therapeutic agent is to be delivered to the patient, how to protect the phage-based agent from immune attack by the patient's body, and how to handle the expected development of phage-resistant pathogens.
On the other hand, phages are and have for decades been widely used as tools in recombinant DNA technology: important in applications and developing applications ranging from medical diagnostics and forensics to basic research. See above, History of bacteriophage research, and our page Major discoveries made with bacteriophages.
|